United States · FDA National Drug Code directory
LORAZEPAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13107-084_67012944-0947-4e64-adab-869993f2f709
- Product NDC
- 13107-084
- Form
- TABLET
- Composition / generic term
- LORAZEPAM
- Labeler
- Aurolife Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210201
- Source listing expiry
- 20261231
Source-listed ingredients
- LORAZEPAM — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (13107-084-01) · 13107-084-01
- 500 TABLET in 1 BOTTLE (13107-084-05) · 13107-084-05
- 10 TABLET in 1 BOTTLE (13107-084-10) · 13107-084-10
- 1000 TABLET in 1 BOTTLE (13107-084-99) · 13107-084-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →